ArticleInternational journal of women's health2026
Silent but Destructive: Ureteral Deep Infiltrating Endometriosis Progressing to Renal Injury - A Case Report.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Ureteral endometriosis is a rare form of deep infiltrating endometriosis that may lead to silent ureteral obstruction and progressive renal injury. Early diagnosis remains challenging because symptoms are often nonspecific. Case Report: A 41-year-old nulliparous woman presented with lower abdominal pain radiating to the rectum and thigh. Pelvic examination revealed an immobile posterior cervical mass. Transvaginal ultrasound demonstrated a deep infiltrating endometriosis nodule associated with hydroureter and grade IV hydronephrosis, which was confirmed by magnetic resonance imaging. Surgical management was recommended; however, the patient declined surgery and opted for conservative treatment. She received monthly leuprolide acetate injections for three months. Follow-up evaluation showed reduction in lesion size and improvement in pain symptoms. Conclusion: Ureteral endometriosis should be considered in reproductive-age women with unexplained hydroureteronephrosis. Hormonal therapy may provide temporary symptom control in patients refusing surgery, although careful follow-up is required because of the risk of ongoing renal damage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.